Senior insider sale
General Counsel at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$850.4K
12.44K shares
What this filing means
WAHL BRYAN plans to sell 12.44K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $850.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/19/2026ACC: 0001959173-26-002516
Officer· General Counsel
Since Jan 2021
12.44K
Shares to sell
$850.4K
Approx. market value
4.23K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/18/2026
4.23KTotal acquired4.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/18/2026 | Restricted Stock Vesting Compensation | 4.23K | — |
| Total | 4.23K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.13K
Market value
$283.4K
3/18/2026
—Completed
Units to sell
4.08K
Market value
$283.5K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.23K
Market value
$283.5K
3/19/2026
Total
Units
12.44K
Value
$850.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/18/2026 | 4.13K | $283.4K | — | Completed |
3/17/2026 | 4.08K | $283.5K | — | Completed |
| Planned — Approximate Date | ||||
3/19/2026 | 4.23K | $283.5K | NASDAQ | Planned |
| Total | 12.44K | $850.4K | ||